These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
463 related items for PubMed ID: 16360345
1. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. Jolly S, Newton G, Horlick E, Seidelin PH, Ross HJ, Husain M, Dzavik V. Am J Cardiol; 2005 Dec 15; 96(12):1617-20. PubMed ID: 16360345 [Abstract] [Full Text] [Related]
2. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Tsagalou EP, Kanakakis J, Anastasiou-Nana MI, Drakos SG, Ntalianis AS, Malliaras K, Lazaris N, Katsaros F, Nanas JN. Acute Card Care; 2009 Dec 15; 11(2):99-106. PubMed ID: 19353405 [Abstract] [Full Text] [Related]
3. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan. Russ MA, Prondzinsky R, Carter JM, Schlitt A, Ebelt H, Schmidt H, Lemm H, Heinroth K, Soeffker G, Winkler M, Werdan K, Buerke M. Crit Care Med; 2009 Dec 15; 37(12):3017-23. PubMed ID: 19661807 [Abstract] [Full Text] [Related]
4. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration. Garber PJ, Mathieson AL, Ducas J, Patton JN, Geddes JS, Prewitt RM. Can J Cardiol; 1995 Jan 15; 11(1):30-6. PubMed ID: 7850662 [Abstract] [Full Text] [Related]
5. Effects of continuous vasopressin infusion in patients with septic shock. Obritsch MD, Jung R, Fish DN, MacLaren R. Ann Pharmacother; 2004 Jan 15; 38(7-8):1117-22. PubMed ID: 15178740 [Abstract] [Full Text] [Related]
6. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock. Rokyta R, Pechman V. Neuro Endocrinol Lett; 2006 Jan 15; 27(1-2):121-7. PubMed ID: 16648778 [Abstract] [Full Text] [Related]
7. Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: effects on hemodynamics and tissue oxygenation. Perez P, Kimmoun A, Blime V, Levy B. Shock; 2014 Apr 15; 41(4):269-74. PubMed ID: 24509521 [Abstract] [Full Text] [Related]
8. Effect of prolonged intra-aortic balloon pumping in patients with cardiogenic shock following acute myocardial infarction. Li JL, Xue H, Wang BS, Zhang HY, Yin LH, Shun WD, Wu Y, Wang LX. Med Sci Monit; 2007 Jun 15; 13(6):CR270-74. PubMed ID: 17534233 [Abstract] [Full Text] [Related]
9. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants. Meyer S, Löffler G, Polcher T, Gottschling S, Gortner L. Acta Paediatr; 2006 Oct 15; 95(10):1309-12. PubMed ID: 16982509 [Abstract] [Full Text] [Related]
10. [High-dose nitroglycerin in cardiogenic shock]. Guglina ME. Klin Med (Mosk); 1997 Oct 15; 75(6):27-30. PubMed ID: 9273395 [Abstract] [Full Text] [Related]
11. [Dopamine in patients with cardiogenic shock (author's transl)]. Kikis D, Esser H, Trübestein G. Med Klin; 1977 Jul 15; 72(28-29):1212-7. PubMed ID: 329088 [Abstract] [Full Text] [Related]
12. Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock. Simoons ML, Muskens G, Hugenholtz PG. Herz; 1983 Feb 15; 8(1):34-40. PubMed ID: 6832691 [Abstract] [Full Text] [Related]
13. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Katz JN, Stebbins AL, Alexander JH, Reynolds HR, Pieper KS, Ruzyllo W, Werdan K, Geppert A, Dzavik V, Van de Werf F, Hochman JS, TRIUMPH Investigators. Am Heart J; 2009 Oct 15; 158(4):680-7. PubMed ID: 19781431 [Abstract] [Full Text] [Related]
14. Pharmacologic support in cardiogenic shock. Rude RE. Adv Shock Res; 1983 Oct 15; 10():35-49. PubMed ID: 6349299 [Abstract] [Full Text] [Related]
15. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Levy B, Perez P, Perny J, Thivilier C, Gerard A. Crit Care Med; 2011 Mar 15; 39(3):450-5. PubMed ID: 21037469 [Abstract] [Full Text] [Related]
16. ["Cardiac power output" an old tool, possibly a modern tool for assessing cardiac pumping capability, as well as for a short-term prognosis in cardiogenic shock due to acute myocardial infarction]. Lupi Herrera E, Chuquiure Valenzuela E, González Pacheco H, Cuéllar Velasco BM, Arias Mendoza A, Martínez Sánchez CR. Arch Cardiol Mex; 2006 Mar 15; 76(1):95-108. PubMed ID: 16749510 [Abstract] [Full Text] [Related]
17. Low-dose vasopressin in the treatment of vasodilatory septic shock. Malay MB, Ashton RC, Landry DW, Townsend RN. J Trauma; 1999 Oct 15; 47(4):699-703; discussion 703-5. PubMed ID: 10528604 [Abstract] [Full Text] [Related]
18. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine. El Mokhtari NE, Arlt A, Meissner A, Lins M. Eur J Med Res; 2007 Nov 05; 12(11):563-7. PubMed ID: 18024265 [Abstract] [Full Text] [Related]
19. [Hemodynamics after prindolol and digitalis in acute myocardial infarction (author's transl)]. Bachour G, Bender F, Hochrein H. Med Klin; 1976 Mar 05; 71(10):414-20. PubMed ID: 57564 [Abstract] [Full Text] [Related]